Kit ELISA Fas Ligand sandwich (FasL) (rat): quantitative assay of Rt FasL in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Rt FasL.
Kit ELISA Fas Ligand sandwich (FasL) (rat): quantitative assay of Rt FasL in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Rt FasL.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
CD178 (Lignand Fas, FasL) is a type II membrane protein, whose N-terminal end is in the cytoplasm and the C-terminal region extends into the extracellular space. The receptor, FasR, is a cell surface type I membrane protein and a member of the tumour necrosis factor (TNF) and nerve growth factor (NGF) receptor family. As a member of the TNF-cytokine CD178 family, he induced apoptosis during interaction with FasR. CD178 may exist as a bound (45 kD) or soluble (26 kD) membrane. The soluble protein can be released from the cells during cleavage by metalloproteinases. The binding of CD178 to Fas leads to receptoroligomerization and triggers death of apoptotic cells by interaction of other proteins. CD178 is expressed predominantly in activated T-cells and natural killer cells (NK) and also in tissues of immunological sites such as testicles and eyes. CD178 expression is also reported in various tissues such as thymus, liver, l CD178 is assumed to be the predominant factor in antiviral immune responses. CD178 is a cell surface molecule belonging to the tumour necrosis factor family, binding to its Fas receptor, thus inducing l-apoptosis. Different cells express Fas, where CD178 is expressed mainly on activated T cells. Fas and CD178 are involved in the downward regulation of immune reactions and T cell cytotoxicity. It has also been shown that CD178 concentration is associated with atherosclerosis and inflammatory disease in patients with hypertension. It has been shown that the Fas/CD178 system plays a role in a number of human diseases, such as AIDS, hepatitis or cancer.
Sensitivity
Sensitivity of the dosage: 90 pg/ml.
Measurement range
Dose range: 82.30-60.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15495373 |
| Specifications |
| Accession number | P36940 |
| Dose range | 82.30-60.000 pg/ml |
| Sensitivity of the dosage | 90 pg/ml |
| Calibration range | 90 pg/ml to 60000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Other proteins |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit has no cross-reactivity with the following tested rat cytokines: CNI-2, CNIC-3, CNTF, fractalkin, IL-1 alpha, IL-1 beta, IL-4, IL-6, IL-10, GM-CSF, IFN-gamma, leptine, Lix, MCP-1, MIP-3 alpha, beta-NGF, TIMP-1, TNF-alpha. |
| Sufficient for | 96 dosages |
| Target species | Rat |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 25385 |
| Gene symbol(s) | Faslig |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Apoptosis |
| Synonym | Apt1Lg1, CD95-L, Fasl, Tnfsf6 |
| Target | Rat |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | ERFASLG |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.